Sangivamycin is primarily used in research settings to study its effects on cellular processes, particularly in cancer research. It acts as an inhibitor of protein synthesis and has shown potential in suppressing the growth of certain tumor cells. Researchers utilize Sangivamycin to investigate its mechanism of action, which involves interfering with RNA and DNA synthesis, making it a valuable tool in understanding cancer cell behavior. Additionally, it has been explored for its antiviral properties, particularly in inhibiting the replication of certain viruses. While not widely used in clinical applications, Sangivamycin remains a significant compound in experimental studies aimed at developing new therapeutic strategies.